Carlsmed Inc.
Organization details
- Legal name
- Carlsmed Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Carlsbad
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CARL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001794546
- EIN
- 83-1081863
Board of directors
-
Jonathan D. Root · DirectorSince 2025
-
Kevin C. Oboyle · DirectorSince 2025
-
Kevin Sidow · DirectorSince 2025
-
Michael Cordonnier · Director · CEO, PresidentSince 2025
-
Niall Casey · Director · Chief IP OfficerSince 2025
-
Philip M. Young · DirectorSince 2025
-
Robert Mittendorff II · DirectorSince 2025
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
85.9% a year in revenue
20% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Director election results
Annual meeting of June 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
93.0%
-
93.6%
Board connections
2 of this board's directors also sit on 4 other boards. 4 are in the same sector.
-
Edgewise Therapeutics Inc. Same sectorvia Jonathan D. Root
-
Omada Health Inc. Same sectorvia Jonathan D. Root
-
Outset Medical Inc. Same sectorvia Kevin C. Oboyle
-
iRhythm Holdings Inc. Same sectorvia Kevin C. Oboyle
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,658,798
- 5 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 3, 2026 | Bertolini Jeffrey Officer (Chief Operating Officer) | Option exercise | +747 | $5.92 | $4,419 |
| Nov 3, 2026 | Bertolini Jeffrey Officer (Chief Operating Officer) | Open-market sale | −747 | $15.15 | $11,317 |
| Oct 30, 2026 | Bertolini Jeffrey Officer (Chief Operating Officer) | Option exercise | +243 | $2.23 | $542 |
| Oct 30, 2026 | Bertolini Jeffrey Officer (Chief Operating Officer) | Open-market sale | −243 | $15.80 | $3,839 |
| Oct 5, 2026 | Bertolini Jeffrey Officer (Chief Operating Officer) | Option exercise | +747 | $5.92 | $4,419 |
| Oct 5, 2026 | Bertolini Jeffrey Officer (Chief Operating Officer) | Open-market sale | −747 | $14.39 | $10,749 |
| Sep 30, 2026 | Bertolini Jeffrey Officer (Chief Operating Officer) | Option exercise | +243 | $2.23 | $542 |
| Sep 30, 2026 | Bertolini Jeffrey Officer (Chief Operating Officer) | Open-market sale | −243 | $13.99 | $3,400 |
| Sep 28, 2026 | Heppenstall Richard Officer (CFO, Treasurer) | Grant or award | +89,286 | — | — |
| Jun 3, 2026 | Kevin C. Oboyle Director | Grant or award | +13,698 | — | — |
| Jun 3, 2026 | Kevin Sidow Director | Grant or award | +13,698 | — | — |
| Jun 3, 2026 | Jonathan D. Root Director | Grant or award | +13,698 | — | — |
| Jun 3, 2026 | Philip M. Young Director | Grant or award | +13,698 | — | — |
| Mar 3, 2026 | Michael Cordonnier Director, Officer (CEO, President) | Option exercise | +160,567 | $0.34 | $54,593 |
| Mar 3, 2026 | Michael Cordonnier Director, Officer (CEO, President) | Option exercise | +33,264 | $4.35 | $144,698 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Carlsmed Inc.
Who is the CEO of Carlsmed Inc.?
Michael Cordonnier has been Carlsmed Inc.'s CEO, President since July 2025.
How many directors are on Carlsmed Inc.'s board?
Carlsmed Inc.'s board has 7 directors: Jonathan D. Root, Kevin C. Oboyle, Kevin Sidow, Michael Cordonnier, Niall Casey, Philip M. Young and Robert Mittendorff II.
Are Carlsmed Inc. insiders buying or selling shares?
Over the last 12 months, Carlsmed Inc. insiders made no open-market purchases and sold $2.7 million of shares in 5 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="carlsmed-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.